Lv1
60 积分 2023-01-29 加入
Comment on “Development of nomograms to predict outcomes for large hepatocellular carcinoma after liver resection”
19小时前
待确认
CT-based intratumoral and peritumoral radiomics to predict the treatment response to hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 in high-risk hepatocellular carcinoma cases: a multi-center study
19小时前
待确认
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
1天前
已完结
Efficacy and Safety of Transarterial Chemoembolization Combined with Lenvatinib Plus Programmed Death-1 Inhibitor for Hepatocellular Carcinoma with the Hepatic Vein and/or Inferior Vena Cava Tumor Thrombus
2天前
已完结
Combining immune checkpoint inhibitors and molecular-targeted agents with hepatic arterial infusion chemotherapy for hepatocellular carcinoma with inferior vena cava and/or right atrium tumor thrombus
2天前
已完结
Aggressive Resection of Hepatocellular Carcinoma with Right Atrial Involvement
3天前
已完结
Thoughts on “Noncontrast magnetic resonance imaging vs ultrasonography for hepatocellular carcinoma surveillance”
7天前
已关闭
Combining immune checkpoint inhibitors and molecular-targeted agents with hepatic arterial infusion chemotherapy for hepatocellular carcinoma with inferior vena cava and/or right atrium tumor thrombus
7天前
已完结
A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus
7天前
已关闭
Efficacy and safety of radiotherapy versus transarterial chemoembolization in combination with lenvatinib and camrelizumab for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: a multicenter study
7天前
已完结
皖公网安备34019202002308
